Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy
Authors
Keywords
-
Journal
Frontiers in Bioengineering and Biotechnology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-05
DOI
10.3389/fbioe.2022.949704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Liquid exfoliation of TiN nanodots as novel sonosensitizers for photothermal-enhanced sonodynamic therapy against cancer
- (2021) Xianwen Wang et al. Nano Today
- Regulatory Mechanism of MicroRNA Expression in Cancer
- (2020) Zainab Ali Syeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targets for Therapy of Bladder Cancer
- (2020) Christof Seidl SEMINARS IN NUCLEAR MEDICINE
- Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine
- (2020) Jana Ghitman et al. MATERIALS & DESIGN
- Titanium-based nanomaterials for cancer theranostics
- (2020) Xianwen Wang et al. COORDINATION CHEMISTRY REVIEWS
- Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
- (2020) Ye Liang et al. Bioactive Materials
- Single-cell microRNA-mRNA co-sequencing reveals non-genetic heterogeneity and mechanisms of microRNA regulation
- (2019) Nayi Wang et al. Nature Communications
- Recent Advances Of Biomimetic Nano-systems in the Diagnosis and Treatment of Tumor
- (2019) Anning Li et al. Asian Journal of Pharmaceutical Sciences
- MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis
- (2018) Xiaobing Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- MicroRNA
- (2018) Thomas X. Lu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Regulatory T cell-targeted hybrid nanoparticles combined with immuno-checkpoint blockage for cancer immunotherapy
- (2018) Wenquan Ou et al. JOURNAL OF CONTROLLED RELEASE
- RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy
- (2018) Shuang Fu et al. JOURNAL OF DRUG TARGETING
- Delivery Strategies for Immune Checkpoint Blockade
- (2018) Qian Chen et al. Advanced Healthcare Materials
- MicroRNA‑34a suppresses breast cancer cell proliferation and invasion by targeting Notch1
- (2018) Xiaoping Rui et al. Experimental and Therapeutic Medicine
- Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
- (2018) Sara Musetti et al. ACS Nano
- Mesoporous silica nanoparticles for therapeutic/diagnostic applications
- (2018) Samira Jafari et al. BIOMEDICINE & PHARMACOTHERAPY
- Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy
- (2018) Yu Xia et al. International Journal of Nanomedicine
- Bladder cancer
- (2017) Michelle Grayson NATURE
- Alternative mechanisms of miR-34a regulation in cancer
- (2017) Eva Slabáková et al. Cell Death & Disease
- Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
- (2017) David Liu et al. Nature Communications
- PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy
- (2017) Renate Pichler et al. Oncotarget
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
- (2017) Katyayani Tatiparti et al. Nanomaterials
- Bladder cancer
- (2017) Oner Sanli et al. Nature Reviews Disease Primers
- The role of PD-L1 in the radiation response and clinical outcome for bladder cancer
- (2016) Chun-Te Wu et al. Scientific Reports
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence
- (2015) Angeline S. Andrew et al. INTERNATIONAL JOURNAL OF CANCER
- Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
- (2014) Nishant S. Gandhi et al. JOURNAL OF CONTROLLED RELEASE
- MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44
- (2014) Gan Yu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
- (2014) Heng Li et al. Molecular Cancer
- Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
- (2013) Elaine Bigelow et al. Jove-Journal of Visualized Experiments
- In Vivo Biodistribution and Clearance Studies Using Multimodal Organically Modified Silica Nanoparticles
- (2010) Rajiv Kumar et al. ACS Nano
- Radiolabeled Cyclic RGD Peptides as Integrin αvβ3-Targeted Radiotracers: Maximizing Binding Affinity via Bivalency
- (2009) Shuang Liu BIOCONJUGATE CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now